- Home
- MTCH vs HALO Comparison
MTCH vs HALO Comparison
Compare MTCH & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTCH | HALO |
|---|---|---|
| Founded | 1986 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 7.4B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | MTCH | HALO |
|---|---|---|
| Price | $33.18 | $62.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 12 |
| Target Price | $35.00 | ★ $73.33 |
| AVG Volume (30 Days) | ★ 2.9M | 2.4M |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | N/A | ★ 56.68 |
| EPS | 2.15 | ★ 4.74 |
| Revenue | ★ $3,469,367,000.00 | $1,242,852,000.00 |
| Revenue This Year | $2.06 | $34.83 |
| Revenue Next Year | $3.46 | $24.84 |
| P/E Ratio | $15.46 | ★ $13.07 |
| Revenue Growth | N/A | ★ 31.19 |
| 52 Week Low | $26.39 | $46.26 |
| 52 Week High | $39.20 | $79.50 |
Technical Indicators
Market Signals| Indicator | MTCH | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 48.86 | 34.09 |
| Support Level | $33.35 | $61.23 |
| Resistance Level | $34.35 | $63.26 |
| Average True Range (ATR) | 0.73 | 2.42 |
| MACD | 0.03 | -0.79 |
| Stochastic Oscillator | 35.98 | 7.60 |
Price Performance
Historical ComparisonAbout MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.